Table of Contents
1 Industry Overview
    1.1 Biologics and Biosimilars Industry
                Figure Biologics and Biosimilars Industry Chain Structure
        1.1.1 Overview
        1.1.2 Development of Biologics and Biosimilars
    1.2 Market Segment
        1.2.1 Upstream
                Table Upstream Segment of Biologics and Biosimilars
        1.2.2 Downstream
                Table Application Segment of Biologics and Biosimilars
                Table Global Biologics and Biosimilars Market 2016-2026, by Application, in USD Million
        1.2.3 COVID-19 Impact
    1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
    2.1 Policy
    2.2 Economics
    2.3 Sociology
    2.4 Technology
3 Biologics and Biosimilars Market by Type
    3.1 By Type
        3.1.1 Antibody
                Table Major Company List of Antibody
        3.1.2 Hormone
                Table Major Company List of Hormone
        3.1.3 Growth Factors
                Table Major Company List of Growth Factors
        3.1.4 Others
                Table Major Company List of Others
    3.2 Market Size
                Table Global Biologics and Biosimilars Market 2016-2020, by Type, in USD Million
                Figure Global Biologics and Biosimilars Market Growth 2016-2020, by Type, in USD Million
                Table Global Biologics and Biosimilars Market 2016-2020, by Type, in Volume
                Figure Global Biologics and Biosimilars Market Growth 2016-2020, by Type, in Volume
    3.3 Market Forecast
                Table Global Biologics and Biosimilars Market Forecast 2021-2026, by Type, in USD Million
                Table Global Biologics and Biosimilars Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
    4.1 Roche (Company Profile, Sales Data etc.)
        4.1.1 Roche Profile
                Table Roche Overview List
        4.1.2 Roche Products & Services
        4.1.3 Roche Business Operation Conditions
                Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.2 Amgen (Company Profile, Sales Data etc.)
        4.2.1 Amgen Profile
                Table Amgen Overview List
        4.2.2 Amgen Products & Services
        4.2.3 Amgen Business Operation Conditions
                Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.3 AbbVie (Company Profile, Sales Data etc.)
        4.3.1 AbbVie Profile
                Table AbbVie Overview List
        4.3.2 AbbVie Products & Services
        4.3.3 AbbVie Business Operation Conditions
                Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.4 Sanofi-Aventis (Company Profile, Sales Data etc.)
        4.4.1 Sanofi-Aventis Profile
                Table Sanofi-Aventis Overview List
        4.4.2 Sanofi-Aventis Products & Services
        4.4.3 Sanofi-Aventis Business Operation Conditions
                Table Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.5 Johnson & Johnson (Company Profile, Sales Data etc.)
        4.5.1 Johnson & Johnson Profile
                Table Johnson & Johnson Overview List
        4.5.2 Johnson & Johnson Products & Services
        4.5.3 Johnson & Johnson Business Operation Conditions
                Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.6 Pfizer (Company Profile, Sales Data etc.)
        4.6.1 Pfizer Profile
                Table Pfizer Overview List
        4.6.2 Pfizer Products & Services
        4.6.3 Pfizer Business Operation Conditions
                Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.7 Novo Nordisk (Company Profile, Sales Data etc.)
        4.7.1 Novo Nordisk Profile
                Table Novo Nordisk Overview List
        4.7.2 Novo Nordisk Products & Services
        4.7.3 Novo Nordisk Business Operation Conditions
                Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.8 Eli Lilly (Company Profile, Sales Data etc.)
        4.8.1 Eli Lilly Profile
                Table Eli Lilly Overview List
        4.8.2 Eli Lilly Products & Services
        4.8.3 Eli Lilly Business Operation Conditions
                Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.9 Novartis (Company Profile, Sales Data etc.)
        4.9.1 Novartis Profile
                Table Novartis Overview List
        4.9.2 Novartis Products & Services
        4.9.3 Novartis Business Operation Conditions
                Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.10 Merck (Company Profile, Sales Data etc.)
        4.10.1 Merck Profile
                Table Merck Overview List
        4.10.2 Merck Products & Services
        4.10.3 Merck Business Operation Conditions
                Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.11 3sbio (Company Profile, Sales Data etc.)
        4.11.1 3sbio Profile
                Table 3sbio Overview List
        4.11.2 3sbio Products & Services
        4.11.3 3sbio Business Operation Conditions
                Table Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.12 Changchun High Tech (Company Profile, Sales Data etc.)
        4.12.1 Changchun High Tech Profile
                Table Changchun High Tech Overview List
        4.12.2 Changchun High Tech Products & Services
        4.12.3 Changchun High Tech Business Operation Conditions
                Table Business Operation of Changchun High Tech (Sales Revenue, Cost, Gross Margin)
    4.13 CP Guojian (Company Profile, Sales Data etc.)
        4.13.1 CP Guojian Profile
                Table CP Guojian Overview List
        4.13.2 CP Guojian Products & Services
        4.13.3 CP Guojian Business Operation Conditions
                Table Business Operation of CP Guojian (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.14 Biotech (Company Profile, Sales Data etc.)
        4.14.1 Biotech Profile
                Table Biotech Overview List
        4.14.2 Biotech Products & Services
        4.14.3 Biotech Business Operation Conditions
                Table Business Operation of Biotech (Sales Revenue, Cost, Gross Margin)
    4.15 Gelgen (Company Profile, Sales Data etc.)
        4.15.1 Gelgen Profile
                Table Gelgen Overview List
        4.15.2 Gelgen Products & Services
        4.15.3 Gelgen Business Operation Conditions
                Table Business Operation of Gelgen (Sales Revenue, Cost, Gross Margin)
    4.16 Innovent (Company Profile, Sales Data etc.)
        4.16.1 Innovent Profile
                Table Innovent Overview List
        4.16.2 Innovent Products & Services
        4.16.3 Innovent Business Operation Conditions
                Table Business Operation of Innovent (Sales Revenue, Cost, Gross Margin)
    4.17 Dong Bao (Company Profile, Sales Data etc.)
        4.17.1 Dong Bao Profile
                Table Dong Bao Overview List
        4.17.2 Dong Bao Products & Services
        4.17.3 Dong Bao Business Operation Conditions
                Table Business Operation of Dong Bao (Sales Revenue, Cost, Gross Margin)
    4.18 Ganlee (Company Profile, Sales Data etc.)
        4.18.1 Ganlee Profile
                Table Ganlee Overview List
        4.18.2 Ganlee Products & Services
        4.18.3 Ganlee Business Operation Conditions
                Table Business Operation of Ganlee (Sales Revenue, Cost, Gross Margin)
    4.19 United Laboratories (Company Profile, Sales Data etc.)
        4.19.1 United Laboratories Profile
                Table United Laboratories Overview List
        4.19.2 United Laboratories Products & Services
        4.19.3 United Laboratories Business Operation Conditions
                Table Business Operation of United Laboratories (Sales Revenue, Cost, Gross Margin)
5 Market Competition
    5.1 Company Competition
                Table Global Biologics and Biosimilars Sales Revenue 2016-2020, by Company, in USD Million
                Table Global Biologics and Biosimilars Sales Revenue Share 2016-2020, by Company, in USD Million
                Figure Global Biologics and Biosimilars Sales Revenue Share in 2020, by Company, in USD Million
                Table Global Biologics and Biosimilars Sales Volume 2016-2020, by Company, in Volume
                Table Global Biologics and Biosimilars Sales Volume Share 2016-2020, by Company, in Volume
                Figure Global Biologics and Biosimilars Sales Volume Share in 2020, by Company, in Volume
    5.2 Regional Market by Company
                Figure North America Biologics and Biosimilars Market Concentration, in 2020
                Figure Europe Biologics and Biosimilars Market Market Concentration, in 2020
                Figure Asia-Pacific Biologics and Biosimilars MMarket Concentration, in 2020
                Figure South America Biologics and Biosimilars Market Concentration, in 2020
                Figure Middle East & Africa Biologics and Biosimilars Market Concentration, in 2020
6 Demand by End Market
    6.1 Demand Situation
        6.1.1 Demand in Tumor
                Figure Biologics and Biosimilars Demand in Tumor, 2016-2020, in USD Million
                Figure Biologics and Biosimilars Demand in Tumor, 2016-2020, in Volume
        6.1.2 Demand in Diabetes
                Figure Biologics and Biosimilars Demand in Diabetes, 2016-2020, in USD Million
                Figure Biologics and Biosimilars Demand in Diabetes, 2016-2020, in Volume
        6.1.3 Demand in Cardiovascular
                Figure Biologics and Biosimilars Demand in Cardiovascular, 2016-2020, in USD Million
                Figure Biologics and Biosimilars Demand in Cardiovascular, 2016-2020, in Volume
        6.1.4 Demand in Hemophilia
                Figure Biologics and Biosimilars Demand in Hemophilia, 2016-2020, in USD Million
                Figure Biologics and Biosimilars Demand in Hemophilia, 2016-2020, in Volume
        6.1.5 Demand in Others
                Figure Biologics and Biosimilars Demand in Others, 2016-2020, in USD Million
                Figure Biologics and Biosimilars Demand in Others, 2016-2020, in Volume
    6.2 Regional Demand Comparison
                Table Regional Demand Comparison List
                Table Major Application in Different Regions
    6.3 Demand Forecast
                Table Biologics and Biosimilars Demand Forecast 2021-2026, by Application, in USD Million
                Figure Biologics and Biosimilars Market Growth 2021-2026, by Application, in USD Million
                Figure Biologics and Biosimilars Market Share in 2026, by Application, in USD Million
                Table Biologics and Biosimilars Demand Forecast 2021-2026, by Application, in Volume
                Table Biologics and Biosimilars Market Growth 2021-2026, by Application, in Volume
                Table Biologics and Biosimilars Market Share in 2026, by Application, in Volume
    6.4 Impact of the COVID-19 on the Demand
7 Region Operation
    7.1 Regional Production
                Table Biologics and Biosimilars Production 2016-2020, by Region, in USD Million
                Table Biologics and Biosimilars Production 2016-2020, by Region, in Volume
    7.2 Regional Market
                Table Global Biologics and Biosimilars Market 2016-2020, by Region, in USD Million
                Table Global Biologics and Biosimilars Market Share 2016-2020, by Region, in USD Million
                Table Global Biologics and Biosimilars Market 2016-2020, by Region, in Volume
                Table Global Biologics and Biosimilars Market Share 2016-2020, by Region, in Volume
    7.3 by Region
        7.3.1 North America
            7.3.1.1 Overview
                Figure North America Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
                Figure North America Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
            7.3.1.2 by Country (U.S., Canada, Mexico)
                Table North America Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
                Table North America Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
        7.3.2 Europe
            7.3.2.1 Overview
                Figure Europe Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
                Figure Europe Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
            7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
                Table Europe Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
                Table Europe Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
        7.3.3 Asia-Pacific
            7.3.3.1 Overview
                Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
                Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
            7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
                Table Asia-Pacific Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
                Table Asia-Pacific Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
        7.3.4 South America
            7.3.4.1 Overview
                Figure South America Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
                Figure South America Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
            7.3.4.2 by Country (Brazil, Argentina etc.)
                Table South America Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
                Table South America Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
        7.3.5 Middle East & Africa
            7.3.5.1 Overview
                Figure Middle East & Africa Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
                Figure Middle East & Africa Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
            7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
                Table Middle East & Africa Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
                Table Middle East & Africa Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
    7.4 Regional Import & Export
    7.5 Regional Forecast
                Table Biologics and Biosimilars Market Forecast 2021-2026, by Region, in USD Million
                Table Biologics and Biosimilars Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
    8.1 Price and Margin
        8.1.1 Price Trends
        8.1.2 Factors of Price Change
                Table Price Factors List
        8.1.3 Manufacturers Gross Margin Analysis
    8.2 Marketing Channel
                Figure Marketing Channels Overview
9 Research Conclusion